N-methyl-N-{3-[({2-[5-(propan-2-yl)-1H-1,3-benzodiazol-2-yl]pyrimidin-5-yl}amino)methyl]pyridin-2-yl}methanesulfonamide

ID: ALA5279005

Max Phase: Preclinical

Molecular Formula: C22H25N7O2S

Molecular Weight: 451.56

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)c1ccc2[nH]c(-c3ncc(NCc4cccnc4N(C)S(C)(=O)=O)cn3)nc2c1

Standard InChI:  InChI=1S/C22H25N7O2S/c1-14(2)15-7-8-18-19(10-15)28-21(27-18)20-25-12-17(13-26-20)24-11-16-6-5-9-23-22(16)29(3)32(4,30)31/h5-10,12-14,24H,11H2,1-4H3,(H,27,28)

Standard InChI Key:  HJFKHTMVRLNXHM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
   -3.7284    0.1622    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0138    0.5745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3019    0.1626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3019   -0.6625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0120   -1.0743    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.7284   -0.6662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4977    0.4128    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0269   -0.2408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5190   -0.9084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2018   -0.2408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2109   -0.9554    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0336   -0.9546    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4464   -0.2398    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0372    0.4720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2125    0.4768    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.2716   -0.2398    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6841   -0.9545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5094   -0.9545    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9222   -0.2399    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7449   -0.2406    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.1576   -0.9555    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7484   -1.6674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9238   -1.6721    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5096    0.4747    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6844    0.4747    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9222    1.1893    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.5096    1.9039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5057    1.7728    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6368    0.7767    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4431   -1.0788    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4431   -1.9039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.1576   -0.6662    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  7  8  1  0
  9  8  2  0
  4  9  1  0
  8 10  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
 14 13  1  0
 15 14  2  0
 10 15  1  0
 13 16  1  0
 16 17  1  0
 17 18  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 18 23  1  0
 19 24  1  0
 24 25  1  0
 24 26  1  0
 26 27  1  0
 26 28  2  0
 26 29  2  0
  6 30  1  0
 30 31  1  0
 30 32  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5279005

    ---

Associated Targets(Human)

SRPK1 Tchem Serine/threonine-protein kinase SRPK1 (2359 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 451.56Molecular Weight (Monoisotopic): 451.1790AlogP: 3.55#Rotatable Bonds: 7
Polar Surface Area: 116.76Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.77CX Basic pKa: 0.29CX LogP: 2.82CX LogD: 2.82
Aromatic Rings: 4Heavy Atoms: 32QED Weighted: 0.44Np Likeness Score: -1.52

References

1. Sabnis RW..  (2023)  Novel Serine-Arginine Protein Kinase Inhibitors for Treating Cancer.,  14  (5): [PMID:37197468] [10.1021/acsmedchemlett.3c00132]

Source